- COPD kills more than 3 million people every year
- Study reveals that the prevalence of depression is high among patients with COPD
- Duration of the disease and smoking are the most significant factors associated with depression in COPD patients.
- The disease will become the third biggest cause of death by the year 2030
- Co-morbid depression refers to depression that occurs in the presence of another illness.
A new study substantiates that the prevalence of depression is high among patients with Chronic obstructive pulmonary disease (COPD). According to the study, the factors associated with depression in COPD patients were the duration of the disease, Body Mass Index (BMI), GOLD stage (Global Initiative for COPD) and smoking. Duration of the disease and smoking were the most significant factors associated with depression in COPD.
COPD – a type of obstructive lung disease characterized by long-term poor airflow – is the fourth largest cause of death in the world. According to World Health Organization (WHO), COPD kills more than 3 million people every year.
According to WHO, COPD is a progressive disease, meaning it typically worsens over time. The disease will become the third biggest cause of death by the year 2030, and it is anticipated that mortality rates due to COPD will increase by over 160% over the next two decades. Most COPD patients die because of other co-morbid conditions that accompany COPD rather than the pulmonary disease.
Co-morbid depression refers to depression that occurs in the presence of another illness. People with chronic (long-term) physical illnesses, especially those with conditions that produce a lot of pain, restriction of activity or a poor outlook are all prone to developing depression on top of their existing illness. These include ischemic heart disease, diabetes, hypertension, renal disease, skeletal muscle dysfunction, osteoporosis, and depression.
Dr. Sujeer Khan, Department of Pulmonary Medicine, J.N. Medical College, Belagavi, says that the available evidence suggests that less than one-third of COPD patients with co-morbid depression are receiving appropriate treatments. To address these barriers, an integrated treatment approach is required from the healthcare professionals, patients, and caregivers. In addition, the health-care providers should be ready to provide appropriate resources to improve the quality of service provision and clinical practice.
This cross-sectional study was carried out on consecutive patients with COPD during their routine out- and in-patient visits in KLE’s Dr. Prabhakar Kore Hospital and Medical Research Center, Belagavi from January 2015 to December 2015. The study report published recently in the Indian Journal of Health Science and Biomedical Research KLEU.